E-LIB Suche - Ergebnisse für: Brueckmann, Ines

1

Patient Experience with the SensoReady® Autoinjector Pen ve..:

Jathanakodi, Shrihari ; Both, Charlotte ; Brueckmann, Ines...
Patient Preference and Adherence. 18 (2024) - p. 1107-1118 , 2024

Link: https://doi.org/10.2147/..

2

Filgrastim biosimilar (EP2006): A review of 15 years' post-..:

Gascón, Pere ; Harbeck, Nadia ; Rapoport, Bernardo L....
Critical Reviews in Oncology/Hematology. 196 (2024) - p. 104306 , 2024

Link: https://doi.org/10.1016/..

3

Real-World Effectiveness and Safety of SDZ ETN, an Etanerce..:

Schmalzing, Marc ; Kellner, Herbert ; Askari, Ayman...
Advances in Therapy. 41 (2023) 1 - p. 315-330 , 2023

Link: https://doi.org/10.1007/..

4

Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patien..:

Blauvelt, Andrew ; Leonardi, Craig L. ; Gaylis, Norman...
BioDrugs. 35 (2021) 2 - p. 229-238 , 2021

Link: https://doi.org/10.1007/..

5

Switching to Biosimilar SDZ-ADL in Patients with Moderate-t..:

Wiland, Piotr ; Jeka, Sławomir ; Dokoupilová, Eva...
BioDrugs. 34 (2020) 6 - p. 809-823 , 2020

Link: https://doi.org/10.1007/..

6

Normal and neoplastic nonstem cells can spontaneously conve..:

Chaffer, Christine L. ; Brueckmann, Ines ; Scheel, Christina...
Proceedings of the National Academy of Sciences of the United States of America. 108 (2011) 19 - p. 7950-7955 , 2011

Link: https://www.jstor.org/st..

7

Normal and neoplastic nonstem cells can spontaneously conve..:

Chaffer, Christine L. ; Brueckmann, Ines ; Scheel, Christina...
Proceedings of the National Academy of Sciences. 108 (2011) 19 - p. 7950-7955 , 2011

Link: https://doi.org/10.1073/..

8

Patient Experience with the SensoReady® Autoinjector Pen ve..:

Jathanakodi, Shrihari ; Both, Charlotte ; Brueckmann, Ines...
info:eu-repo/semantics/altIdentifier/doi/10.2147/PPA.S455791. , 2024

Link: https://www.dovepress.co..

9

Filgrastim biosimilar (EP2006) : a review of 15 years' post..:

Gascón, Pere ; Harbeck, Nadia ; Rapoport, Bernardo Leon...
Gascón, P., Harbeck, N., Rapoport, B.L. et al. 2024, 'Filgrastim biosimilar (EP2006): a review of 15 years' post-approval evidence', Critical Reviews in Oncology/Hematology, vol. 196, art. 104306, pp. 1-11, doi : 10.1016/j.critrevonc.2024.104306.. , 2024

Link: http://hdl.handle.net/22..

10

Real-world effectiveness and safety of SDZ ETN, an etanerce..:

Schmalzing, Marc ; Kellner, Herbert ; Askari, Ayman...
https://doi.org/10.1007/s12325-023-02706-8. , 2023

Link: http://hdl.handle.net/21..

11

Role of proinflammatory markers and NT-proBNP in patients w..:

Streitner, Florian ; Kuschyk, Juergen ; Veltmann, Christian...
Cytokine. 47 (2009) 3 - p. 166-172 , 2009

Link: https://doi.org/10.1016/..

12

Prospective study of interleukin-6 and the risk of malignan..:

Streitner, Florian ; Kuschyk, Juergen ; Veltmann, Christian...
Cytokine. 40 (2007) 1 - p. 30-34 , 2007

Link: https://doi.org/10.1016/..